4D-150
AXP000259.1 · Viral vector gene therapy
- Platform
- AAV R100 capsid (4DMT)
- Originator
- 4D Molecular Therapeutics
- Sponsor
- 4D Molecular Therapeutics
Names
| Name | Type | Source |
|---|---|---|
| 4D-150 | preferred name, code | curator, ctgov |
Virus
- Role
- In vivo gene transfer
- Family
- Parvoviridae
- Virus
- adeno-associated virus (R100 capsid variant)
- Strain
- R100
- Replication
- non replicating
- Modifications
- synthetic capsid-derived sequence (R100), for intravitreal delivery
- Route
- intravitreal
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (5)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT07867080 | A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME). | Recruiting | Phase 3 | 2026-09-18 | 2029-01 | 514 | Diabetic Macular Edema (DME) |
| NCT07064759 | Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration | Recruiting | Phase 3 | 2025-07-22 | 2027-11 | 480 | Neovascular Age-Related Macular Degeneration (nAMD) |
| NCT06864988 | 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration | Active not recruiting | Phase 3 | 2025-03-03 | 2027-06 | 480 | Macular Neovascularization Secondary to Age-Related Macular Degeneration |
| NCT05930561 | 4D-150 in Patients With Diabetic Macular Edema | Active not recruiting | Phase 2 | 2023-08-09 | 2029-02-28 | 72 | Diabetic Macular Edema; Diabetic Retinopathy |
| NCT05197270 | 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration | Recruiting | Phase 1/2 | 2021-12-09 | 2027-03 | 215 | Neovascular (Wet) Age-Related Macular Degeneration |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 39620832 | Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies. | Investigative ophthalmology & visual science | 2024 | cited by trial NCT05197270 |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 41490387 | Emerging solutions for neovascular age-related macular degeneration. | Current opinion in ophthalmology | 2026 | name in abstract: 4D-150 |
| PMID 41688763 | AAV-based gene therapies for neovascular AMD. | Gene therapy | 2026 | name in abstract: 4D-150 |
| PMID 39379521 | Exploring new horizons in neovascular age-related macular degeneration: novel mechanisms of action and future therapeutic avenues. | Eye (London, England) | 2025 | name in abstract: 4D-150 |
| PMID 40293479 | Gene therapy in neovascular age related macular degeneration: an update. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2025 | name in abstract: 4D-150 |
| PMID 40319468 | Beyond the injection: delivery systems reshaping retinal disease management. | Expert opinion on pharmacotherapy | 2025 | name in abstract: 4D-150 |
| PMID 40364236 | Gene Therapy in Diabetic Retinopathy and Diabetic Macular Edema: An Update. | Journal of clinical medicine | 2025 | name in abstract: 4D-150 |
| PMID 38927656 | Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and Beyond. | Genes | 2024 | name in abstract: 4D-150 |
Notes
Intravitreal gene therapy for neovascular AMD on 4DMT's customised R100 capsid, designed to block more than one VEGF family member. Phase 1/2 NCT05197270 (published) and phase 3 NCT07064759 (4FRONT programme). The exact transgene cargo is not taken from a primary source here, so `transgenes` is empty.
How to cite
4D-150 (AXP000259.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000259.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.